Loading data for TEVA — first visit, this takes a few seconds.
Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA
· Real-Time Price · USD
36.44
-1.18 (-3.14%)
At close: Aug 28, 2026, 8:00 PM
36.30
-0.38%
After-hours: 7:55 PM
The price, the headline numbers and the latest news, in one place.
Teva Pharmaceutical Industries Limited (TEVA) Stock Price, Analysis & Data
No data available
| Bid | 35.7 |
| Market Cap | 42.5B |
| Revenue (ttm) | 17.3B |
| Net Income (ttm) | 706M |
| 0.88 | |
| 0.58 | |
| 62.83 | |
| 11.85 | |
| P/B (ttm) | 5.48 |
| P/S (ttm) | 2.45 |
| Earnings Date | Nov 4, 2026 |
| Ask | 36.39 |
| Volume | 3,138,885 |
| Avg. Volume (20D) | 5,661,601 |
| Open | 37.37 |
| Previous Close | 37.62 |
| Day's Range | 36.37 - 37.42 |
| 52-Week Range | 18.14 - 38.37 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | Nov 27, 2017 |
About TEVA
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral...
Sector Healthcare
IPO Date Feb 16, 1982
Employees 31,173
Stock Exchange NYSE
Ticker Symbol TEVA
Website https://www.tevapharm.com
Financial Performance
In 2025, Teva Pharmaceutical Industries's revenue was 17.26B, an increase of 4.31% compared to the previous year's 16.54B. Earnings were 1.41B, a decrease of -186.03%.
Financial StatementsEarnings Surprise
Teva Pharmaceutical Industries has released their quarterly earnings on Jul 29, 2026:
- Revenue of $4.14B misses estimates by $0, with -0.81% YoY decline.
- EPS of 0.02 misses estimates by -0.09, with -96.97% YoY decline.
Teva Pharmaceutical Industries Limited is scheduled to release its earnings on Nov 4, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2